A new blood test that is said to accurately detect congenital disorders such as Down, Patau and Edwards' syndromes has been recommended for high-risk women on the National Health Service. Called ...
European Non-Invasive Prenatal Testing (NIPT) Market · GlobeNewswire Inc. Dublin, Dec. 30, 2024 (GLOBE NEWSWIRE) -- The "Europe Non-Invasive Prenatal Testing (NIPT) Market: Focus on Method, Platform, ...
Non-invasive prenatal testing (NIPT) for chromosomal fetal disorders is used increasingly to test for conditions such as Down's syndrome. NIPT examines DNA from the fetus in the mother's blood, and ...
Australian Non-Invasive Prenatal Testing (NIPT) Market · GlobeNewswire Inc. Dublin, Jan. 14, 2025 (GLOBE NEWSWIRE) -- The "Australia Non-Invasive Prenatal Testing (NIPT) Market: Focus on Technology, ...
The Global Non-Invasive Prenatal Testing (NIPT) Market is expected to grow at 16% by 2029. The high risk of chromosomal abnormalities with rising maternal age, the surge in the adoption of cell-free ...
Dublin, April 25, 2025 (GLOBE NEWSWIRE) -- The "United States Non-Invasive Prenatal Testing (NIPT) Market Report 2025: Industry Size, Market Shares Data, Latest Trends, Insights, Growth Potential, ...
DUBLIN, Feb. 14, 2020 /PRNewswire/ -- The "Non-Invasive Prenatal Testing (NIPT) Market by Product and Solution (Consumables, Systems, Software), Method (Ultrasound Screening, Cell Free DNA Test), ...
A research team from Odense University Hospital and the University of Southern Denmark has developed an innovative screening test. With a blood sample from the expectant mother, they can scrutinize ...
(MENAFN- GlobeNewsWire - Nasdaq) Rising demand for early genetic screenings, technological advancements, and increased awareness are key growth drivers. With improved prenatal care and expanded ...
Dublin, Dec. 30, 2024 (GLOBE NEWSWIRE) -- The "Europe Non-Invasive Prenatal Testing (NIPT) Market: Focus on Method, Platform, End User, Application, and Country - Analysis and Forecast, 2023-2033" ...
Non-invasive prenatal testing (NIPT) for chromosomal foetal disorders is used increasingly to test for conditions such as Down's syndrome. NIPT examines DNA from the foetus in the mother's blood, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results